Literature DB >> 20537788

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.

Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, Amjad P Khan, Qi Cao, Jindan Yu, Bharathi Laxman, Rohit Mehra, Robert J Lonigro, Yong Li, Mukesh K Nyati, Aarif Ahsan, Shanker Kalyana-Sundaram, Bo Han, Xuhong Cao, Jaeman Byun, Gilbert S Omenn, Debashis Ghoshd, Subramaniam Pennathur, Danny C Alexander, Alvin Berger, Jeffrey R Shuster, John T Wei, Sooryanarayana Varambally, Christopher Beecher, Arul M Chinnaiyan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20537788      PMCID： PMC3919522          DOI： 10.1016/j.eururo.2010.05.003

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.

Authors:  Florian Jentzmik; Carsten Stephan; Kurt Miller; Mark Schrader; Andreas Erbersdobler; Glen Kristiansen; Michael Lein; Klaus Jung
Journal:  Eur Urol       Date:  2010-01-26       Impact factor: 20.096

2.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962
  2 in total
  5 in total

Review 1.  Application of metabolomics to prostate cancer.

Authors:  Bruce J Trock
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

2.  Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

Authors:  Matthew J Roberts; Horst J Schirra; Martin F Lavin; Robert A Gardiner
Journal:  Korean J Urol       Date:  2011-02-19

3.  Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Stella Koutros; Tamra E Meyer; Stephen D Fox; Haleem J Issaq; Timothy D Veenstra; Wen-Yi Huang; Kai Yu; Demetrius Albanes; Lisa W Chu; Gerald Andriole; Robert N Hoover; Ann W Hsing; Sonja I Berndt
Journal:  Carcinogenesis       Date:  2013-05-22       Impact factor: 4.944

Review 4.  Pathway and network approaches for identification of cancer signature markers from omics data.

Authors:  Jinlian Wang; Yiming Zuo; Yan-Gao Man; Itzhak Avital; Alexander Stojadinovic; Meng Liu; Xiaowei Yang; Rency S Varghese; Mahlet G Tadesse; Habtom W Ressom
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

5.  Programming bulk enzyme heterojunctions for biosensor development with tetrahedral DNA framework.

Authors:  Ping Song; Juwen Shen; Dekai Ye; Baijun Dong; Fei Wang; Hao Pei; Jianbang Wang; Jiye Shi; Lihua Wang; Wei Xue; Yiran Huang; Gang Huang; Xiaolei Zuo; Chunhai Fan
Journal:  Nat Commun       Date:  2020-02-11       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.